SkinHealth Systems (SKIN) Gains from Investment Securities (2020 - 2025)
SkinHealth Systems' (SKIN) quarterly Gains from Investment Securities came in at -$138000.0 in Q4 2025, down 97.14% year-over-year from -$4.8 million in Q4 2024, and up 34.29% quarter-over-quarter from -$210000.0 in Q3 2025.
Powered by 
Analysis
SkinHealth Systems (SKIN) Gains from Investment Securities (2020 - 2025) Analysis & Trends
SkinHealth Systems (SKIN) has reported Gains from Investment Securities for 6 consecutive years, with -$138000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Gains from Investment Securities fell 97.14% year-over-year to -$138000.0 in Q4 2025; TTM through Jun 2026 was -$348000.0, a 44.5% increase from a year earlier, with the FY2025 full-year figure at -$487000.0, up 84.12% from the prior year.
- Gains from Investment Securities was -$138000.0 for Q4 2025 at SkinHealth Systems, up from -$210000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $199.3 million in Q3 2021 and troughed at -$52.1 million in Q1 2022.
- A 5-year average of $9.4 million and a median of -$349000.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 2374.0% in 2022 and surged 117.44% in 2023, its largest moves.
- Over 5 years, Gains from Investment Securities stood at $300000.0 in 2021, then tumbled by 2374.0% to -$6.8 million in 2022, then jumped by 47.89% to -$3.6 million in 2023, then soared by 98.03% to -$70000.0 in 2024, then sank by 97.14% to -$138000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$138000.0 (Q4 2025), -$210000.0 (Q3 2025), and $210000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | SkinHealth Systems | 89.77 Mn | -116.30 Mn | 49.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -138,000.00 |
| Sep 30, 2025 | -210,000.00 |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | -349,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Sep 30, 2024 | -418,000.00 |
| Jun 30, 2024 | -4.04 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -5.86 Mn |
| Jun 30, 2023 | -11.59 Mn |
| Mar 31, 2023 | 9.08 Mn |
| Dec 31, 2022 | -6.82 Mn |
| Sep 30, 2022 | -4.28 Mn |
| Jun 30, 2022 | -15.19 Mn |
| Mar 31, 2022 | -52.05 Mn |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 199.31 Mn |
| Jun 30, 2021 | 72.03 Mn |
| Dec 31, 2020 | 36.79 Mn |